ID: ALA3087362

Max Phase: Preclinical

Molecular Formula: C27H36N3O3+

Molecular Weight: 450.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccccn1

Standard InChI:  InChI=1S/C27H35N3O3/c31-25(29-24-11-5-8-16-28-24)20-30-17-12-21(13-18-30)23(19-30)33-26(32)27(22-9-3-4-10-22)14-6-1-2-7-15-27/h3-5,8-9,11,16,21,23H,1-2,6-7,10,12-15,17-20H2/p+1/t21?,23-,30?/m0/s1

Standard InChI Key:  UYYIYNBXGLEYLK-WITHESGTSA-O

Associated Targets(Human)

Liver microsome 8277 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 7750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 1154 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.60Molecular Weight (Monoisotopic): 450.2751AlogP: 4.40#Rotatable Bonds: 6
Polar Surface Area: 68.29Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.15CX Basic pKa: 3.93CX LogP: -0.07CX LogD: -0.07
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.40Np Likeness Score: 0.17

References

1. Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V..  (2013)  The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.,  23  (23): [PMID:24144851] [10.1016/j.bmcl.2013.09.092]

Source